Global Immunotherapy Drug Market Demand and Growth 2018-2024
18-May-2018 | Number of pages: 190 | Report Id: BMRC PH 119 | Report Format: | Status: Upcoming

Global Immunotherapy Drug Market Demand and Growth 2018-2024

Brandessence Market Research is working on a new report titleImmunotherapy Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″.Increasing geriatric population and adoption of targeted therapies with lesser side effects are major key factor which drives the Immunotherapy Drug Market.

Immunotherapy Drug Market Reports –

Immunotherapy is a type of cancer treatment that enhances the body’s natural defenses to fight the cancerous tissues. In this therapy substances made by the body or in a laboratory are used to improve or restore immune system function.There are several types of immunotherapy such as Monoclonal antibodies, Non-specific immunotherapies,Oncolytic virus therapy, T-cell therapy and Cancer vaccines.The drug used for this therapy is called Immunotherapy Drugs.Immunotherapy drugs are designed to alert the immune system about mutated cells so it can find and destroy them easily. Such as,Ipilimumab, Atizolizumab, Avelumab, Pembrolizumab and Nivolumab. Some Side effects of Immunotherapy are Fatigue, Fever, Chills, Weakness, Nausea, Vomiting, Dizziness, High or Low Blood Pressure, Headache, Diarrhea and Cough.

Immunotherapy Drug Market is segmented on the basis of Therapy Area, Types of Drugs, End user and Geography. Based upon Therapy DrugImmunotherapy Drug Market is classified as Cancer, Autoimmune & inflammatory diseases, Infectious Diseases and Others.Based on the type of DrugImmunotherapy Drug Market is classified into Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors,Interferons, Alpha & Beta Interleukins and Others. On the basis of End users Autologous Stem Cell and Non Stem Based therapies Market is classified into Hospitals, Clinics and Others.

The regions covered in Immunotherapy Drug Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Immunotherapy Drug Market Reports –

Immunotherapy Drug Market reports cover prominent players likeF. Hoffmann-La Roche AG, GlaxoSmithKline Inc., Amgen, Inc., Merck & Co., Inc., Bristol-Myers Squibb, Novartis International AG, Johnson & Johnson, AstraZeneca Plc,OPKO Health, Inc., Myriad Genetics Inc, Koninklijke Philips N.V, Qiagen, Illumina, Inc., Abbott, PerkinElmer, Inc., Genomic Health, Inc., Sysmex Corporation, AbbVie, Inc., Eli Lilly and Company, Alder Biopharmaceuticals, ChemoCentryx, Boehringer Ingelheim,Argos Therapeutics, Agenus, CTI BioPharma, AVAX Technologies, ADC Therapeutics, Biothera, Biogen, Aduro Biotech, Acorda Therapeutics,Advaxis, CoherusBioSciences and Bavarian Nordic.

Immunotherapy Drug Market Dynamics –

Rising adoption of targeted therapies with fewer side effects, quicker drug approval processes and highest prevalence rate of lifestyle diseases such as atherosclerosis, heart disease,  stroke,  obesity, type 2 diabetes  and diseases associated with smoking and alcohol and drug abuse is anticipated to fuel the immunotherapy drugs market growth. Moreover, Materialization of biosimilars is another driving factor for the immunotherapy drugs market.However, the high cost of immunotherapy treatment such as Current checkpoint inhibitors each have a price approximate $150,000 a year. A combination of Yervoy and Opdivo approved byFDA(Food and Drug Administration) for advanced or impossibletumorhas a cost of $256,000 per one year for patients who respond to the treatment. Thus high cost ofdrug can affect the growth of immunotherapy drug market.Nonetheless, growing opportunities in the emerging markets and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy.

Immunotherapy Drug Market Regional Analysis –

North America is probable to attain the largest share of the Immunotherapy Drug Market in terms of revenue and expected to hold the positionfollowed by Europe region.This isDue to favorable government initiatives, increased expenditure on Research and Development, personalized medicineand availability of technologically advanced health care research framework. Asia Pacific is likely to achieve a high growth rate of the immunotherapy drugs market in the next few years due to development of health care infrastructure, high disposable income, rise in health and hygiene related awareness, large untapped market base, and economic development.Prosperous middle class willing to spend on quality healthcare products is driving the Immunotherapy drug Market.Furthermore, increased awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.

 Key Benefits for Immunotherapy Drug Market Reports –

  • Immunotherapy Drug Market report covers in depth historical and forecast analysis.
  • Immunotherapy Drug Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Immunotherapy Drug Marketreport helps to identify opportunities in market place.
  • Immunotherapy Drug Market report covers extensive analysis of emerging trends and competitive landscape.

Immunotherapy Drug Market Segmentation

 Immunotherapy Drug Market: By Therapy Area Analysis

  • Cancer
  • Solid Tumor
  • Malignant
  • Autoimmune & Inflammatory Diseases
  • Infectious Diseases
  • Others

Immunotherapy Drug Market: By Type of Drugs Analysis

  • Monoclonal Antibodies
  • Adult Vaccines
  • Preventive Vaccines
  • Therapeutic Vaccines
  • Checkpoint Inhibitors
  • Alpha & BetaInterferons
  • Interleukins
  • Others

Immunotherapy Drug Market: By End User Analysis

  • Hospitals
  • Clinics
  • Others

Immunotherapy Drug Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Immunotherapy Drug Market 2018-2024

Our 190 pages report provides 76 tables, 64 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Immunotherapy Drug Market
  • To receive forecasts of Immunotherapy Drug Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Immunotherapy Drug Marketsector
  • To determine the forces and factor that influences the market for Immunotherapy Drug Market: drivers, restraints, opportunities and threats
  • To find out where theImmunotherapy Drug Marketis heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Immunotherapy Drug Market: By Region Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

 Immunotherapy Drug Market: By Therapy Area Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Cancer XX XX XX XX XX
Autoimmune and Inflammatory Diseases XX XX XX XX XX
Infectious Diseases XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

 Immunotherapy Drug Market: By Type of Drug Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Monoclonal Antibodies XX XX XX XX XX
Adult Vaccines XX XX XX XX XX
Checkpoint Inhibitors XX XX XX XX XX
Alpha and Beta Interferons XX XX XX XX XX
Interlukins XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Immunotherapy Drug Market: By End User Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Hospitals XX XX XX XX XX
Clinics XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

 Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey ofImmunotherapy Drug Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email us today to order this report or to ask for assistance. We look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  •  Bristol-Myers Squibb
  • Novartis International AG
  • Johnson & Johnson
  • AstraZeneca Plc
  • OPKO Health, Inc.
  • Myriad Genetics Inc.
  • Koninklijke Philips N.V
  • Qiagen
  • Illumina, Inc.
  • Abbott
  • PerkinElmer, Inc.
  • Genomic Health, Inc.
  • Sysmex Corporation
  • AbbVie, Inc.
  • Eli Lilly and Company
  • Alder Biopharmaceuticals
  • ChemoCentryx
  • Boehringer Ingelheim
  • Argos Therapeutics
  • Agenus
  • CTI BioPharma
  • AVAX Technologies
  • ADC Therapeutics
  • Biothera
  • Biogen
  • Aduro Biotech
  • Acorda Therapeutics
  • Advaxis
  • Coherus BioSciences
  • Bavarian Nordic
  • Others

  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  •  Bristol-Myers Squibb
  • Novartis International AG
  • Johnson & Johnson
  • AstraZeneca Plc
  • OPKO Health, Inc.
  • Myriad Genetics Inc.
  • Koninklijke Philips N.V
  • Qiagen
  • Illumina, Inc.
  • Abbott
  • PerkinElmer, Inc.
  • Genomic Health, Inc.
  • Sysmex Corporation
  • AbbVie, Inc.
  • Eli Lilly and Company
  • Alder Biopharmaceuticals
  • ChemoCentryx
  • Boehringer Ingelheim
  • Argos Therapeutics
  • Agenus
  • CTI BioPharma
  • AVAX Technologies
  • ADC Therapeutics
  • Biothera
  • Biogen
  • Aduro Biotech
  • Acorda Therapeutics
  • Advaxis
  • Coherus BioSciences
  • Bavarian Nordic
  • Others